Reirradiation of recurent glioblastomas: High prognostic significance of contrast-enhancing tumor volume (2021) Mansoorian S, Coras R, Weissmann T, Lettmaier S, Semrau S, Frey B, Bert C, et al. Conference contribution Cell-Cannibalism by Normal Tissue Cells as a Survival Benefit after Irradiation of Normal Tissue Cells leads to an Increase in their Activity as non-professional Phagocytes (2021) Sonntag T, Distel L, Fietkau R Conference contribution App for the Early Detection of Side Effects of Immunotherapy (2021) Goldbrunner L, Hecht M, Fietkau R, Distel L Conference contribution The IMMO-LDRT01 Study - Analgesic and immunomodulatory Effects of LDRT in Patients with chronic degenerative and inflammatory Diseases (2021) Donaubauer AJ, Fröhlich B, Becker I, Weissmann T, Fietkau R, Ott O, Gaipl U, Frey B Conference contribution Website on the individual Radiation Sensitivity of Tumor Patients (2021) Rzepka D, Fietkau R, Distel L Conference contribution Proliferating non-professional Phagocytes to generate Cell-in-Cell Structures (2021) Hofmann A, Fietkau R, Distel L Conference contribution Tumor-infiltrating Memory T Cells in Head and Neck Tumors: An ambivalent prognostic Factor (2021) Hartan R, Schnellhardt S, Büttner-Herold M, Daniel C, Fietkau R, Distel L Conference contribution Expression of Immune Phenotypes in Rectal Cancer after neoadjuvant Chemoradiotherapy (2021) Schnellhardt S, Hirneth J, Büttner-Herold M, Daniel C, Fietkau R, Distel L Conference contribution Evaluation of a dedicated Treatment Planning-MRI for Patients with cranial Stereotaxy (2021) Grigo J, Masitho S, Putz F, Fietkau R, Bert C Conference contribution Longitudinal Spread Analysis of Patients with Glioblastoma: high Prevalence of discontinuous Tumor Foci with no strong Relation to the Fibrous Tract System (2021) Schmitter C, Weissmann T, Mansoorian S, Lettmaier S, Semrau S, Schmidt M, Heiß R, et al. Conference contribution